series-b
Stage
2011
Founded
3
Investors
About
Eyevensys is a clinical-stage biotechnology company developing non-viral gene therapies for ophthalmic diseases, utilizing an electrotransfection system to deliver DNA plasmids encoding therapeutic proteins into the ciliary muscle to sustainably treat major eye diseases such as wet age-related macular degeneration and geographic atrophy.
Explore Eyevensys's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.